Aflac Incorporated (NYSE:AFL – Get Free Report) has received a consensus rating of “Hold” from the fifteen analysts that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $97.93.
AFL has been the subject of several recent research reports. Citigroup boosted their target price on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Piper Sandler boosted their price objective on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Truist Financial lifted their target price on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Bank of America increased their price target on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Finally, Barclays began coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price objective on the stock.
Check Out Our Latest Report on Aflac
Institutional Inflows and Outflows
Aflac Stock Performance
Shares of Aflac stock opened at $111.32 on Tuesday. The business has a 50-day simple moving average of $110.41 and a 200 day simple moving average of $99.48. The firm has a market capitalization of $61.84 billion, a price-to-earnings ratio of 16.77, a PEG ratio of 2.13 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac has a one year low of $75.07 and a one year high of $115.50.
Aflac (NYSE:AFL – Get Free Report) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The company had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. Aflac’s revenue for the quarter was down 40.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.84 earnings per share. On average, research analysts anticipate that Aflac will post 7.22 earnings per share for the current fiscal year.
Aflac Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 annualized dividend and a dividend yield of 1.80%. Aflac’s payout ratio is presently 30.12%.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Health Care Stocks Explained: Why You Might Want to Invest
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The 3 Best Retail Stocks to Shop for in August
- Time to Load Up on Home Builders?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.